SurgiTech and Amendia, a spinal implants and surgical instrumentation company, has entered into a license agreement for the patented SurgiFile Spinal Decompression System.

The Northeast Indiana Regional Partnership and OrthoWorx are now collaborating on mutually beneficial projects, according to an OrthoWorx news release.

Integra LifeSciences has acquired Ascension Orthopedics for approximately $65 million in cash, according to a joint news release.

Here is a breakdown of the company share percentage for the global orthopedic implants market, according to GBI Research's "The Future of Orthopedic Implants, Analysis and Forecasts to 2016 - Joint Reconstruction and Spinal Implants Creating Growth Opportunities."

1. Advanced Biologics (Ladera Ranch, Calif.). The company's OsteoAMP exploits growth factors within allograft tissue. A proprietary process utilizes the osteoinductivity of autografts and the osteoconductivity of allografts from the same donor to enhance growth factors to higher levels. OsteoAMP won first place in the regenerative technologies category in Best New Technology for 2009 hosted by Orthopedics This Week. OsseoGEN is the company's line of allograft-derived stem cell technology. The company's OsteoMEM, an ultra porous shape memory scaffold, is not currently available in the U.S. market. www.advancedbiologicscorp.com

Here are five things you should know about the global orthopedic implants market, according to GBI Research's "The Future of Orthopedic Implants, Analysis and Forecasts to 2016 - Joint Reconstruction and Spinal Implants Creating Growth Opportunities."

The growth of Amedica Corp., an orthopedic implant company focused on using silicon nitride ceramic technologies to develop spine and total joint implants, and the leadership of Ben Shappley, the company's president, CEO and director, is highlighted in a report by The Salt Lake Tribune.

Stryker Corp. reported that its sales were $1.834 billion for the fourth quarter of 2009, representing a 6.8 percent increase over net sales of $1.718 billion for the fourth quarter of 2008, and were $6.723 billion for the year ended Dec. 31, 2009, representing a 0.1 percent increase from net sales of $6.718 billion for the year ended Dec.31, 2008, according to a Stryker news release.